Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens
1. EW reports Q1 2025 sales of $1.41 billion, beating estimates. 2. Adjusted EPS of 64 cents exceeds consensus by 4 cents. 3. TMTT first-quarter sales grow 58% year-over-year. 4. Company raises 2025 sales guidance to $5.7-$6.1 billion. 5. Piper Sandler upgrades EW's rating to Overweight, targeting $80.